FDAnews Drug Daily Bulletin

Compounder Missed Marks for Sterile Drug Processing, FDA Says

Oct. 26, 2017

An Alabama compounding pharmacy fell short of several standards for sterile drug processing, the FDA said in a Form 483 inspection report.

Included among the findings at the pharmacy, Triad Rx, in Daphne, were: non-sterile wipes, dirty equipment, failure to change used gloves, and an improperly disinfected pump.

In addition, workers processed sterile products with hands, wrists, legs, hair or mouths exposed, the agency said.

View today's stories